Table 1. PROMIS inclusion and exclusion criteria.
Patient inclusion criteria |
Men at least 18 years or over at risk of prostate cancer who have been advised to have a prostate biopsy |
Serum PSA ⩽15ng ml−1 within previous 3 months |
Suspected stage ⩽T2 on rectal examination (organ confined) |
Fit for general/spinal anaesthesia |
Fit to undergo all protocol procedures including a transrectal ultrasound |
Signed informed consent |
Patient exclusion criteria |
Treated using 5-alpha-reductase inhibitors at time of registration or during the prior 6 months |
Previous history of prostate biopsy, prostate surgery or treatment for prostate cancer (interventions for BPH/bladder outflow obstruction are acceptable) |
Evidence of a urinary tract infection or history of acute prostatitis within the last 3 months |
Contraindication to MRI (e.g., claustrophobia, pacemaker, estimated GFR ⩽50) |
Any other medical condition precluding procedures described in the protocol |
Previous history of hip replacement surgery, metallic hip replacement or extensive pelvic orthopaedic metal work. |
Abbreviations: GFR, glomerular filtration rate; MRI, magnetic resonance imaging.